Background illustration for clinical trials search

Paid Clinical Trials Oregon

Discover 1,087 paid clinical trials in Oregon. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.

for
Advanced Solid Tumors
Location: Fairfax VA, Grand Rapids MI, St Louis MO, Houston TX,
Sponsor: FoRx Therapeutics AG

Sex: All

Age: 18+

Code: NCT07356453

Phase 1, Recruiting

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

for
Epithelial Ovarian Cancer
Location: Burlington MA, Towson MD, Washington D.C. DC,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07218809

Phase 3, Recruiting

The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).

for
Mitral Annular Calcification, Mitral Stenosis,
Location: Boston MA, New York NY, Washington D.C. DC, Tulsa OK,
Sponsor: Mayra Guerrero

Sex: All

Age: 18+

Code: NCT04408430

Recruiting

Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)

for
Osteogenesis Imperfecta (OI)
Location: New Haven CT, Wilmington DE, Toronto, Columbus OH,
Sponsor: Angitia Incorporated Limited

Sex: All

Age: 18 - 70+

Code: NCT07062588

Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

for
Focal Seizures
Location: New Haven CT, Hawthorne NY, Edison NJ, New Brunswick NJ,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT07233239

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Scarborough ME, Burlington MA, New Haven CT, Lebanon NH,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07085767

Phase 3, Recruiting

Adaptation of the Family Check-Up Online

for
Substance Use (Drugs, Alcohol)
Location: Eugene OR
Sponsor: University of Oregon

Sex: All

Age: 11 - 14

Code: NCT07025083

Recruiting

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

for
Head and Neck Squamous Cell Carcinoma,
Location: Hackensack NJ, Richmond VA, Pittsburgh PA, Atlanta GA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06980038

Phase 2, Recruiting

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

for
Eosinophilic Asthma
Location: Boston MA, New Haven CT, Philadelphia PA, Durham NC,
Sponsor: Kymera Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07323654

Phase 2, Recruiting

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

for
Overweight, Obesity
Location: New Bedford MA, Hamden CT, Bridgeport CT,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07282600

Phase 3, Recruiting

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

for
Breast Neoplasms, Neoplasm Metastasis
Location: Westbrook ME, Lebanon NH, Summit NJ, Philadelphia PA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07174336

Phase 3, Recruiting

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

for
Asthma
Location: Boston MA, The Bronx NY, Miami FL, Hialeah FL,
Sponsor: Enveda Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07301255

Phase 2, Recruiting

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

for
Squamous Cell Carcinoma of Head and Neck
Location: Boston MA, Hartford CT, New Haven CT, Mineola NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07276399

Phase 3, Recruiting

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

for
Progressive Pulmonary Fibrosis,
Location: Farmington CT, New Haven CT, New York NY,
Sponsor: Avalyn Pharma Inc.

Sex: All

Age: 18+

Code: NCT06951217

Phase 2, Recruiting

The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms

for
Hemorrhagic Stroke, Aneurysm, Intracranial, Saccular Aneurysm,
Location: Boston MA, Stony Brook NY, Manhasset NY, New York NY,
Sponsor: phenox Inc.

Sex: All

Age: 18+

Code: NCT07143019

Recruiting

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: Worcester MA, Hartford CT, Norwalk CT, Danbury CT,
Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07166094

Phase 3, Recruiting

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

for
Intracerebral Hemorrhage
Location: Boston MA, Worcester MA, Stony Brook NY, New York NY,
Sponsor: Joseph Broderick, MD

Sex: All

Age: 18 - 70+

Code: NCT07227246

Phase 3, Recruiting

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Scarborough ME, Providence RI, Farmington CT,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07213804

Phase 3, Recruiting

Topical Ruxolitinib in the Treatment of Adults With Pyoderma Gangrenosum

for
Pyoderma Gangrenosum
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 18 - 70+

Code: NCT07783412

Phase 2, Recruiting

A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With Vitiligo

for
Vitiligo
Location: Miramar FL, Canton MI, Louisville KY, Hot Springs AR,
Sponsor: Teva Branded Pharmaceutical Products R&D LLC

Sex: All

Age: 18 - 70+

Code: NCT06625177

Phase 1, Recruiting

Popular cities in Oregon